Related Experiment Video

Updated: May 30, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding

K M Lee1, W I Choi, D I Koh

  • 1Department of Biochemistry and Molecular Biology, Yonsei University School of Medicine, Seoul, Korea.

Oncogene
|August 2, 2011
PubMed

Insights

Kidney cancer-associated KR-POK protein represses CDKN1A gene transcription by inhibiting MIZ-1, promoting cell proliferation. This mechanism differs from other MIZ-1 interactions.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Epigenetics

Background:

  • The BTB/POZ protein family plays roles in tumorigenesis and cell cycle.
  • Myc-interacting zinc-finger protein 1 (MIZ-1) activates CDKN1A transcription.
  • Kidney cancer-associated KR-POK is a potential proto-oncoprotein overexpressed in cancers.

Purpose of the Study:

  • To investigate the role of KR-POK in kidney cancer.
  • To elucidate the mechanism by which KR-POK affects CDKN1A gene transcription.
  • To understand the interaction between KR-POK and MIZ-1.

Main Methods:

  • BiFC/FRET assay, co-immunoprecipitation, and GST pull-down assays to study protein interactions.
  • Oligonucleotide pull-down and chromatin immunoprecipitation assays to determine DNA binding.
  • Analysis of histone acetylation levels.

Main Results:

  • KR-POK interacts with MIZ-1 via their POZ domains.
  • KR-POK represses CDKN1A transcription by binding to promoter elements and competing with MIZ-1.
  • KR-POK inhibits MIZ-1/p300 recruitment, reducing histone acetylation and promoting cell proliferation.

Conclusions:

  • KR-POK acts as a proto-oncoprotein by interfering with MIZ-1's function in CDKN1A transcription.
  • This mechanism of cell proliferation stimulation is distinct from other MIZ-1-interacting proteins.
  • KR-POK represents a novel therapeutic target in kidney cancer.

More Related Videos

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle10:05

Studying RNA Interactors of Protein Kinase RNA-Activated during the Mammalian Cell Cycle

Published on: March 5, 2019

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.